Why Software as a Medical Device Faces Different Cybersecurity Scrutiny Than Hardware

Medical technology is becoming increasingly software-driven, changing not only how healthcare is delivered but also how medical products must be secured. A physical medical device can remain largely unchanged after it leaves the manufacturing facility, but software can evolve continuously through updates, integrations, changing dependencies, and new connectivity requirements. That difference creates a distinct cybersecurity challenge. When software itself performs a medical purpose, a security weakness may have implications that extend beyond data protection and operational disruption to patient safety, clinical decision-making, and the reliability of care.

This is why Software as a Medical Device, commonly known as SaMD, faces cybersecurity scrutiny that differs from traditional hardware-based devices. Regulators, healthcare organizations, and manufacturers must consider not only how the software works at launch but also how it will behave, change, and remain secure throughout its lifecycle. Cybersecurity has become closely connected with quality, safety, and risk management, requiring a more dynamic approach than the one historically associated with many standalone physical devices.

Software Creates a Continuously Changing Attack Surface

One of the defining differences between SaMD and traditional hardware is the speed at which the software environment can change. A hardware device has physical components, fixed interfaces, and operational limitations. Software, by contrast, may interact with cloud infrastructure, mobile devices, application programming interfaces, operating systems, databases, and third-party services. Every connection can introduce a potential security consideration.

This means that a SaMD product’s cybersecurity posture can change even when its core medical function remains the same. A newly discovered vulnerability in an open-source library, a change in a cloud service, or an update to an operating system may create a risk that did not exist when the product was originally released. Security therefore cannot be evaluated only at a single point in time.

Regulatory and industry expectations increasingly reflect this reality. Organizations such as the FDA and the International Medical Device Regulators Forum have emphasized cybersecurity throughout the medical device lifecycle. The focus extends beyond identifying technical vulnerabilities to understanding how cybersecurity threats could affect the safety and effectiveness of a medical product.

The Consequences of a Cybersecurity Failure Can Be Different

Cybersecurity incidents affect organizations in many industries, but medical technology presents a unique risk environment. A compromised consumer application may result in inconvenience, financial loss, or exposure of personal information. A compromised medical application may potentially interfere with clinical information, medical recommendations, patient monitoring, or other functions that healthcare professionals and patients rely upon.

This connection between cybersecurity and safety changes the way risk must be assessed. A vulnerability cannot be prioritized solely according to its technical severity. Manufacturers must also consider how easily it could be exploited, what system functions could be affected, whether an attacker could influence medical data or functionality, and what consequences could result from a successful attack.

For this reason, cybersecurity risk assessment for SaMD often requires collaboration across multiple disciplines. Software developers understand the architecture, cybersecurity professionals understand attack techniques, quality teams understand risk controls, and clinical experts can help evaluate the potential impact on real-world use. A meaningful security program brings these perspectives together rather than treating cybersecurity as an isolated IT responsibility.

SaMD Cybersecurity Requires Security by Design

Effective SaMD Cybersecurity begins long before a product is released. Security is strongest when it is incorporated into the architecture and development process instead of being added after the software is substantially complete. This approach allows manufacturers to identify potential threats early and design appropriate controls around them.

Threat modeling is particularly valuable because it helps development teams examine how a system might be attacked. Instead of waiting for vulnerabilities to appear during testing or after deployment, teams can analyze possible attack paths involving unauthorized access, compromised credentials, insecure APIs, vulnerable dependencies, improper data handling, or weaknesses in update mechanisms.

Security by design also requires attention to basic engineering practices that are sometimes underestimated in fast-moving software environments. Strong authentication, appropriate authorization, secure communications, input validation, secure logging, dependency management, and controlled update processes all contribute to the overall security posture of a medical software product.

Software Supply Chains Add Another Layer of Scrutiny

Modern SaMD products are rarely built entirely from code created by a single development team. They often rely on open-source components, commercial software libraries, cloud services, development frameworks, operating systems, and external platforms. These dependencies can provide important capabilities, but they can also introduce cybersecurity risks outside the manufacturer’s direct control.

A vulnerability in a third-party component can become a vulnerability in the finished medical software product. The challenge is particularly significant when manufacturers do not have a clear inventory of the software components they use. Without that visibility, it becomes more difficult to determine whether a newly disclosed vulnerability affects a product already in use.

This has contributed to the growing importance of software supply chain management and Software Bills of Materials. Maintaining visibility into components and dependencies helps manufacturers respond more quickly when vulnerabilities emerge. It also supports better communication between developers, security teams, healthcare organizations, and other stakeholders.

Testing Must Go Beyond Intended Functionality

Functional testing is essential for any medical software product, but cybersecurity testing asks a fundamentally different set of questions. Functional testing evaluates whether the software does what it is intended to do. Security testing examines whether someone can cause it to do something it was never intended to do.

This requires testing approaches that reflect realistic threats. Depending on the product, cybersecurity evaluation may involve vulnerability assessments, penetration testing, API testing, access control testing, configuration reviews, dependency analysis, and testing of how the software responds to unexpected or malicious inputs.

The value of these activities is not limited to discovering individual weaknesses. Testing can reveal broader problems in the software’s architecture and security processes. For example, repeated authorization issues may indicate weaknesses in access-control design, while recurring dependency vulnerabilities may suggest the need for stronger component management practices.

Postmarket Cybersecurity Is Especially Important for SaMD

One of the most significant differences in cybersecurity scrutiny is the importance of the postmarket period. Software does not remain static after deployment. New vulnerabilities are discovered, attackers develop new techniques, infrastructure changes, and supporting technologies eventually become outdated.

Manufacturers therefore need processes for monitoring and responding to cybersecurity issues throughout the product’s useful life. This may involve vulnerability intake, risk assessment, remediation planning, validation, coordinated disclosure, customer communication, and the controlled delivery of security updates.

Updates themselves require careful attention. A security patch may resolve one risk while unintentionally creating another problem. In a medical context, manufacturers must consider whether an update could affect performance, reliability, interoperability, or safety. The ability to securely develop, validate, distribute, and monitor updates is therefore an important part of a mature cybersecurity program.

Hardware Devices Face Risks, but the Security Model Is Different

The fact that SaMD faces specialized cybersecurity scrutiny does not mean that hardware-based medical devices are free from cybersecurity concerns. Connected equipment can be exposed through network interfaces, wireless communications, embedded software, service ports, removable media, and other access points.

However, hardware often operates within more clearly defined physical and technical boundaries. Its core components may remain relatively stable throughout its lifecycle. Software can change far more rapidly, and its environment may evolve without any physical modification to the device itself.

A software update can introduce new functionality, create a new connection, modify how information is processed, or change the security profile of the entire product. This creates a level of flexibility that is valuable for innovation but also requires ongoing oversight.

Cybersecurity Documentation Demonstrates More Than Compliance

For medical software manufacturers, cybersecurity documentation plays an important role in demonstrating that security has been addressed systematically. Documentation can show how risks were identified, what controls were implemented, how those controls were tested, and how the organization intends to manage vulnerabilities after release.

This is particularly relevant during regulatory review, but its value extends beyond regulatory requirements. Clear documentation improves communication between teams and creates a record of the decisions made during development. It can also help organizations respond more efficiently when a new vulnerability affects the product.

Strong documentation should reflect the actual security posture of the software rather than becoming a disconnected compliance exercise. A well-written risk assessment is only useful if the development and security practices behind it are genuine. Similarly, a detailed security plan provides limited value if the organization lacks the processes and resources needed to carry it out.

Cybersecurity Must Become a Shared Responsibility

SaMD cybersecurity cannot be owned by one department alone. Developers may build the software, but security decisions can affect regulatory strategy, quality systems, clinical use, customer support, and long-term product management.

A collaborative approach allows organizations to identify risks earlier and make better-informed decisions. Security teams can explain emerging threats, developers can assess technical feasibility, quality professionals can connect controls to risk-management processes, and clinical stakeholders can help determine the potential consequences of a cybersecurity failure.

This shared responsibility also creates a stronger security culture. Instead of treating cybersecurity as an obstacle that delays development, organizations can integrate it into normal product planning and decision-making. Security becomes part of how the product is designed, tested, released, and maintained.

Conclusion

The cybersecurity scrutiny surrounding Software as a Medical Device is different because the nature of software itself is different. SaMD can change rapidly, depend on complex ecosystems, interact with multiple external systems, and remain exposed to new vulnerabilities long after its initial release. These characteristics require manufacturers to think beyond traditional security controls and adopt a lifecycle approach that connects cybersecurity with safety, quality, risk management, and postmarket responsibility.

The most successful approach is not to treat cybersecurity as a final regulatory hurdle or a problem to solve after a vulnerability appears. It is to build security into the foundation of the product and maintain that commitment throughout its lifecycle. As medical software becomes increasingly important to modern healthcare, manufacturers that understand this responsibility will be better positioned to manage risk, maintain trust, and support safer, more resilient technology for the people who depend on it.